SN
SNES.US SenesTech Inc
- Market cap
- USD 5.53M
- P/E
- -
- P/B
- 1.02x
- ROE
- -169.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SNES.US undervalued?
Graham numberThe Graham number of SenesTech Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SenesTech Inc fundamental analysis
No fundamental analysis for SenesTech Inc yet.
SenesTech Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SenesTech Inc
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evo…
Full company profileSenesTech Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SenesTech Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 318K | 52.0K | 297K | 143K | 258K | 576K | 1.02M | 1.19M | 1.86M | 2.22M | 3.15M |
| Gross Profit | 122K | 7.00K | 56.0K | 42.0K | -23.0K | 220K | 464K | 539K | 1.00M | 1.39M | 2.23M |
| Operating Income | -10.5M | -12.3M | -11.9M | -10.3M | -7.93M | -8.93M | -9.67M | -7.73M | -6.25M | -6.51M | -7.96M |
| EBITDA | -10.5M | -11.8M | -11.4M | -9.56M | -7.62M | -7.95M | -9.51M | -7.57M | -6.01M | -6.23M | -7.75M |
| Net Income | -10.8M | -12.3M | -11.9M | -10.0M | -7.94M | -8.27M | -9.70M | -7.71M | -6.18M | -6.38M | -7.80M |
| EPS | -80,560 | -53,886 | -29,475 | -18,449 | -6,339 | -1,773 | -1,860 | -115 | -8.86 | -0.19 | -1.44 |
| Balance Sheet | |||||||||||
| Total Assets | 12.9M | 9.32M | 7.75M | 4.98M | 6.02M | 11.5M | 6.78M | 7.29M | 3.28M | 12.8M | 8.14M |
| Total Liabilities | 2.04M | 1.80M | 1.44M | 2.41M | 2.14M | 1.47M | 1.50M | 942K | 767K | 3.28M | 3.55M |
| Shareholders' Equity | 10.8M | 7.52M | 6.31M | 2.57M | 3.88M | 10.0M | 5.28M | 6.35M | 2.51M | 9.57M | 4.60M |
| Cash & Short-term Investments | 11.8M | 7.12M | 4.92M | 1.94M | 3.64M | 9.33M | 4.78M | 5.40M | 1.31M | 8.57M | 3.95M |
| Total Debt | 219K | 780K | 480K | 954K | 1.44M | 555K | 359K | 406K | 262K | 2.68M | 2.53M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -6.70M | -9.32M | -9.13M | -8.06M | -7.11M | -7.78M | -8.58M | -7.57M | -6.03M | -5.75M | -6.62M |
| Capital Expenditure | 57.0K | 898K | 239K | 71.0K | 114K | 100K | 174K | 149K | 84.0K | 138K | 24.0K |
| Free Cash Flow | -6.75M | -10.2M | -9.37M | -8.13M | -7.22M | -7.88M | -8.75M | -7.72M | -6.12M | -5.89M | -6.64M |
| Ratios | |||||||||||
| ROE | -99.7% | -163.3% | -188.6% | -390.3% | -204.4% | -82.4% | -183.7% | -121.4% | -246.3% | -66.7% | -169.7% |
| ROA | -83.9% | -131.8% | -153.6% | -201.2% | -131.8% | -71.9% | -143.0% | -105.7% | -188.7% | -49.7% | -95.8% |
| Net Profit Margin | -3,394.7% | -23,626.9% | -4,009.4% | -7,005.6% | -3,076.4% | -1,435.4% | -951.4% | -646.3% | -333.0% | -287.4% | -247.9% |
| Debt to Equity | 0.02x | 0.10x | 0.08x | 0.37x | 0.37x | 0.06x | 0.07x | 0.06x | 0.10x | 0.28x | 0.55x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SenesTech Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 17.0K | 3.65 | - |
| 2020 | USD 436K | 348 | - |
| 2019 | USD 55.0K | 101 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:10 on Jul 25, 2024.
Who owns SenesTech Inc
- Insiders 11.69%
- Institutions 42.96%
- Public & others 45.35%
- Shares outstanding 6.82M
- Free float 2.43M
Top funds holding SNES.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Extended Market Index | 36.3K | 0.67% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 7.18K | 0.13% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 891.00 | 0.02% | 0.00% | Sep 2026 |
Top institutions holding SNES.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Sabby Management LLC | 142K | 2.61% | -35.13% | Jun 2026 |
| Citadel Advisors Llc | 46.7K | 0.86% | +312.32% | Jun 2026 |
| Geode Capital Management, LLC | 44.3K | 0.82% | -29.74% | Jun 2026 |
| Vanguard Capital Management, LLC | 34.8K | 0.64% | -18.90% | Jun 2026 |
| Renaissance Technologies Corp | 34.7K | 0.64% | -58.00% | Sep 2026 |
| Vanguard Fiduciary Trust Co | 26.6K | 0.49% | -16.09% | Jun 2026 |
| Essex Investment Management Company, LLC | 26.2K | 0.48% | -0.35% | Jun 2026 |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 19.1K | 0.35% | 0.00% | Jun 2026 |
| Northern Trust Corp | 17.6K | 0.32% | 0.00% | Jun 2026 |
| State Street Corp | 16.7K | 0.31% | 0.00% | Jun 2026 |
| XTX Topco Ltd | 10.3K | 0.19% | -51.06% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 3.40K | 0.06% | 0.00% | Jun 2026 |
| UBS Group AG | 1.31K | 0.02% | -93.74% | Jun 2026 |
| Advisor Group Holdings, Inc. | 1.00K | 0.02% | -80.00% | Jun 2026 |
| Barclays PLC | 106.00 | 0.00% | 0.00% | Jun 2026 |
| Caitong International Asset Management Co., Limited. | 13.00 | 0.00% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| TWO SIGMA SECURITIES, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
SenesTech Inc company profile
- Company name
- SenesTech Inc
- Ticker
- SNES.US
- Exchange
- USA Stocks
- Listed since
- Dec 8, 2016
- Sector
- Basic Materials
- Industry
- Pharmaceuticals
- Employees
- 23
- Fiscal year end
- December
- Address
- 13430 North Dysart Road, Surprise, AZ, United States, 85379
- Phone
- 928 779 4143
- Website
- senestech.com
About SenesTech Inc
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
SenesTech Inc management
4- Mr. Michael EdellPresident & CEO · born 1964
- Mr. Thomas C. Chesterman M.B.A.Executive VP, CFO, Treasurer & Secretary · born 1959
- Mr. Jack KarabeesExecutive VP of Sales
- Robert BlumInvestor Relations